Brazil health regulator says application for Sinovac vaccine lacks information - (Financial Post via NewsPoints Desk)

  • Brazilian health authority Anvisa said that the application from Butantan for emergency use of a COVID-19 vaccine developed by Sinovac Biotech lacks some relevant information for the analysis, as reported Financial Post.

  • According to Anvisa, Butantan did not inform, for instance, the age, gender or comorbidities of trial participants in trials.

  • The application also missed data on the vaccine’s immunogenicity on Phase III trials and some details on the number of participants, the health authority said.

To read more NewsPoints articles, click here.